Intracranial Neurophysiological Signatures of Fear and Anxiety in Humans

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Device, Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Anxiety disorders such as post-traumatic stress disorder (PTSD) and generalized anxiety disorder (GAD) affect a large number of individuals with a significant portion of patients failing to improve with current treatments. The purpose of this study is to understand the brain mechanisms that produce fear and anxiety in humans. To accomplish this goal, we will measure the brain activity along with the heart rate and skin perspiration of patients while they are completing tasks on a computer. Some of the tasks will also use a virtual reality headset and transport the patient in a video game-like environment. These tasks will expose the participants to various levels of fear-provoking images. Participants with responsive neurostimulation (RNS) implants will be enrolled under Pro00117931 at Duke, but their results for fear and anxiety tasks will be reported under NCT05120635.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: t
View:

• 18 years of age or older

• Has undergone acute depth or chronic responsive neurostimulation (RNS) electrode placement

• Willing to provide informed consent and participate in the study

• Ability to read and write English fluently

Locations
United States
California
University of California Los Angeles
RECRUITING
Los Angeles
North Carolina
Duke University Health System
RECRUITING
Durham
Contact Information
Primary
Gabriela Vilchez
suthanalab@duke.edu
9196812577
Time Frame
Start Date: 2021-10-01
Estimated Completion Date: 2026-06-30
Participants
Target number of participants: 80
Treatments
Other: EMU Participants
Subjects participating in the study at the Epilepsy Monitoring Unity (EMU).
Other: RNS Participants
Subjects with RNS implants.
Sponsors
Leads: Duke University
Collaborators: National Institute of Mental Health (NIMH), National Institutes of Health (NIH), VA Greater Los Angeles Healthcare System, NeuroPace

This content was sourced from clinicaltrials.gov